In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ID Biomedical buys Shire's vaccine business for £66.4mm

Executive Summary

As part of a strategy announced almost a year ago to exit the vaccines business, Shire Pharmaceuticals Group PLC is selling all the assets of its Canadian-based vaccines unit Shire Biologics, the subsidiary of Shire BioChem, to ID Biomedical (vaccines and gene identification) for £66.4mm ($120mm) or 4.8 times the unit's 2003 sales revenues.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Includes Contract
    • Full Acquisition

Related Companies